PubMed Health⌕ Search

PubMed · 16729734

Quantum mechanics in structure-based drug design.

Abstract

In principle, quantum mechanics provides a more accurate representation of molecular systems than other modeling approaches. While this notion is not a matter of dispute, it has not yet been definitively demonstrated within the realm of structure-based drug design that the use of quantum mechanical methods over the use of classical modeling approaches is justified in consideration of the increase in expense associated with quantum mechanical methods. Demonstrating that quantum mechanics-based methods can be superior to simpler models, and resolving problems relating to estimating the effects of conformational entropy, will provide key areas of interest in the coming years for in silico structure-based drug design. Recent applications using quantum mechanical methods in structure-based drug design are reviewed herein, and applications ranging from scoring receptor-ligand interactions using quantum mechanics to the generation of quantitative structure-activity relationships using quantum mechanics-derived descriptors are discussed.

Explore related subjects

Keep this discovery

Explore connections, maps & timelines

BibTeXRIS

Martin B Peters, Kaushik Raha, Kenneth M Merz. 2006. Quantum mechanics in structure-based drug design.. https://pubmed.ncbi.nlm.nih.gov/16729734/

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related citations

Strategies to design pyrazolyl urea derivatives for p38 kinase inhibition: a molecular modeling study.

The p38 protein kinase is a serine-threonine mitogen activated protein kinase, which plays an important role in inflammation and arthritis. A combined study of 3D-QSAR and molecular docking has been undertaken to explore the structural insights of pyrazolyl urea p38 kinase inhibitors. The 3D-QSAR studies involved comparative molecular field analysis (CoMFA) and comparative molecular similarity indices (CoMSIA). The best CoMFA model was derived from the atom fit alignment with a cross-validated r (2 )(q (2)) value of 0.516 and conventional r (2) of 0.950, while the best CoMSIA model yielded a q (2) of 0.455 and r (2) of 0.979 (39 molecules in training set, 9 molecules in test set). The CoMFA and CoMSIA contour maps generated from these models provided inklings about the influence of interactive molecular fields in the space on the activity. GOLD, Sybyl (FlexX) and AutoDock docking protocols were exercised to explore the protein-inhibitor interactions. The integration of 3D-QSAR and molecular docking has proffered essential structural features of pyrazolyl urea inhibitors and also strategies to design new potent analogues with enhanced activity.

Drug Design↗